USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 131 filers reported holding USANA HEALTH SCIENCES INC in Q2 2013. The put-call ratio across all filers is 15.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $361,920 | +66551.9% | 8,000 | -28.6% | 0.00% | -50.0% |
Q1 2024 | $543 | -14.8% | 11,200 | -5.9% | 0.00% | -33.3% |
Q4 2023 | $637 | -0.2% | 11,900 | +9.2% | 0.00% | 0.0% |
Q3 2023 | $638 | -2.6% | 10,900 | +4.8% | 0.00% | 0.0% |
Q2 2023 | $655 | -65.6% | 10,400 | -65.7% | 0.00% | 0.0% |
Q1 2023 | $1,905 | +262.2% | 30,300 | +206.1% | 0.00% | +50.0% |
Q4 2022 | $526 | -99.9% | 9,900 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $554,000 | -22.6% | 9,900 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $716,000 | -11.6% | 9,900 | -2.9% | 0.00% | 0.0% |
Q1 2022 | $810,000 | -13.9% | 10,200 | +9.7% | 0.00% | 0.0% |
Q4 2021 | $941,000 | -1.8% | 9,300 | -10.6% | 0.00% | -25.0% |
Q3 2021 | $958,000 | -4.5% | 10,400 | +6.1% | 0.00% | 0.0% |
Q2 2021 | $1,003,000 | +3.8% | 9,800 | -1.0% | 0.00% | 0.0% |
Q1 2021 | $966,000 | +18.2% | 9,900 | -6.6% | 0.00% | +33.3% |
Q4 2020 | $817,000 | +24.7% | 10,600 | +19.1% | 0.00% | 0.0% |
Q3 2020 | $655,000 | +0.3% | 8,900 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $653,000 | +9.9% | 8,900 | -13.6% | 0.00% | 0.0% |
Q1 2020 | $594,000 | -26.6% | 10,300 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $809,000 | -46.2% | 10,300 | -53.2% | 0.00% | 0.0% |
Q3 2019 | $1,504,000 | +93.3% | 22,000 | +124.5% | 0.00% | 0.0% |
Q2 2019 | $778,000 | +2.0% | 9,800 | +7.7% | 0.00% | 0.0% |
Q1 2019 | $763,000 | -14.7% | 9,100 | +19.7% | 0.00% | -40.0% |
Q4 2018 | $894,000 | -11.7% | 7,600 | -9.5% | 0.01% | +25.0% |
Q3 2018 | $1,012,000 | -4.5% | 8,400 | -8.7% | 0.00% | -20.0% |
Q2 2018 | $1,060,000 | +13.2% | 9,200 | -15.6% | 0.01% | +25.0% |
Q1 2018 | $936,000 | +9.1% | 10,900 | -6.0% | 0.00% | 0.0% |
Q4 2017 | $858,000 | +11.9% | 11,600 | -12.8% | 0.00% | +33.3% |
Q3 2017 | $767,000 | -1.0% | 13,300 | +9.9% | 0.00% | 0.0% |
Q2 2017 | $775,000 | +7.6% | 12,100 | -3.2% | 0.00% | 0.0% |
Q1 2017 | $720,000 | -7.3% | 12,500 | -1.6% | 0.00% | 0.0% |
Q4 2016 | $777,000 | -1.4% | 12,700 | +122.8% | 0.00% | -25.0% |
Q3 2016 | $788,000 | +10.5% | 5,700 | -10.9% | 0.00% | +33.3% |
Q2 2016 | $713,000 | -2.1% | 6,400 | +6.7% | 0.00% | 0.0% |
Q1 2016 | $728,000 | -5.0% | 6,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $766,000 | -4.7% | 6,000 | 0.0% | 0.00% | -25.0% |
Q3 2015 | $804,000 | -6.5% | 6,000 | -4.8% | 0.00% | 0.0% |
Q2 2015 | $860,000 | +4.6% | 6,300 | -14.9% | 0.00% | 0.0% |
Q1 2015 | $822,000 | +2.8% | 7,400 | -5.1% | 0.00% | +33.3% |
Q4 2014 | $800,000 | -45.1% | 7,800 | -60.6% | 0.00% | 0.0% |
Q3 2014 | $1,458,000 | +88.4% | 19,800 | +100.0% | 0.00% | 0.0% |
Q2 2014 | $774,000 | +0.8% | 9,900 | -2.9% | 0.00% | 0.0% |
Q1 2014 | $768,000 | -2.3% | 10,200 | -1.9% | 0.00% | -25.0% |
Q4 2013 | $786,000 | -17.7% | 10,400 | -5.5% | 0.00% | 0.0% |
Q3 2013 | $955,000 | +11.8% | 11,000 | -6.8% | 0.00% | 0.0% |
Q2 2013 | $854,000 | – | 11,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |